Adagene Inc. (ADAG) income statement
ADAGNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 1, 2026Score 5/30
$1.82+0.34 (+22.97%)
Close on Nov 18, 2026Market cap $107.80MP/E –Yield –
Adagene Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, FY2025
- Gross margin
- –
- Operating margin
- -279.5%
- Net margin
- -229.6%
- Return on equity, FY2025
- -41.0%
Financial strength
- Current ratio
- 5.02
- Debt to equity
- 0.06
- Debt to assets
- 4.3%
- Cash to current liabilities
- 485.2%
Valuation
- P/E ratio
- –
- Price to sales
- 14.05
- Price to book
- 1.21
- Dividend yield
- –
See a number that looks wrong?